Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
33.5
Year-on-year revenue growth (%)Wording
Conditional
How definitive the wording is.Contents of this document
Presentation materials for financial results2024年9月期 第3四半期7 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥30,711 million+33.5%
Operating profit¥8,158 million+32.1%
Net income¥5,741 million+24.4%
Operating profit margin26.6 %
Selling, general and administrative expensesAmount not stated
Results for the three months of the current quarter
Net Sales
¥11,118 million
EBITDA
¥3,315 million
margin_pct29.8
Operating profit
¥2,824 million
margin_pct25.4
Net income
¥1,946 million
margin_pct17.5
Full-year earnings forecast
Net Sales
¥42,638 million
EBITDA
¥12,340 million
Operating profit
¥10,500 million
Net income
¥7,255 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales72
EBITDA76.8
Net income79.1
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
通期予想対比で堅調に推移New initiatives
- 医療法人香徳会との連携による医心館 関中央の開設決定
- 医心館事業のノウハウを活用した地域医療再生事業への展開構想
Key KPIsA metric the company considers important as a management benchmark.
- Occupancy rate at existing facilities87.1 %
- Occupancy rate at new facilities50~55中央値
- Number of facilities95 FacilityYear on year against the same period last year25施設増
- Capacity4,770 PeopleYear on year against the same period last year約38%増
- MSCI ESG RatingAAYear on year against the same period last yearUpgraded by one notch from A
Medium-term management plan targets
Plan nameAmvis 2025
Target fiscal year2025年9月期または2025年9月末
Target value
Number of facilities131施設
Capacity6,621名
Net Sales565.5億円
EBITDA166.0億円
Net income for the current fiscal year95.2億円
当期純利益年平均成長率25% or higher
Comparison with actual results22年9月期・23年9月期実績および24年9月期予想と対比
Market Size / Share
Market Size Indicator
- 東京都：一都道府県あたり平均年間がん死亡者数34,799人
- 大都市圏：19,419人
- 地方：5,515人
施設数の推移
Tokyo Metropolitan Government5施設から19施設
Major metropolitan areas26施設から54施設
Regional policy27施設から52施設
Number of stores and locations
Number at period-end95施設（2024年6月末）
Number of store openings and closures during the period第3四半期に8施設を開設
Annual Dividend
Annual dividend per share¥4
End of period¥4
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | 2024年9月期 第3四半期 |
| Net Sales | ¥30,711 million (YoY +33.5%) |
| Operating profit | ¥8,158 million (YoY +32.1%) |
| Net income | ¥5,741 million (YoY +24.4%) |
| Operating profit margin | 26.6 % |
| Selling, general and administrative expenses | 非開示 |
| Results for the three months of the current quarter | Net Sales ¥11,118 million / EBITDA ¥3,315 million / Operating profit ¥2,824 million / Net income ¥1,946 million |
| Full-year earnings forecast | Net Sales ¥42,638 million / EBITDA ¥12,340 million / Operating profit ¥10,500 million / Net income ¥7,255 million |
| Progress against full-year forecast | Net Sales 72 / EBITDA 76.8 / Net income 79.1 |
| Self-assessment against the plan | 通期予想対比で堅調に推移 |
| Key KPIs | Indicator name Occupancy rate at existing facilities / Value 87.1 % / Year on year against the same period last year Not disclosed, Indicator name Occupancy rate at new facilities / Value 50~55 / Year on year against the same period last year Not disclosed, Indicator name Number of facilities / Value 95 Facility / Year on year against the same period last year 25施設増, Indicator name Capacity / Value 4,770 People / Year on year against the same period last year 約38%増, Indicator name MSCI ESG Rating / Value AA / Year on year against the same period last year Upgraded by one notch from A |
| Number of stores and locations | Number at period-end 95施設（2024年6月末） / Number of store openings and closures during the period 第3四半期に8施設を開設 |
| Medium-term management plan targets | Plan name Amvis 2025 / Target fiscal year 2025年9月期または2025年9月末 / Target value Number of facilities 131施設 / Capacity 6,621名 / Net Sales 565.5億円 / EBITDA 166.0億円 / Net income for the current fiscal year 95.2億円 / 当期純利益年平均成長率 25% or higher / Comparison with actual results 22年9月期・23年9月期実績および24年9月期予想と対比 |
| Annual Dividend | Annual dividend per share ¥4 / Interim Not disclosed / End of period ¥4 |
| Market Size / Share | Market Size Indicator 東京都：一都道府県あたり平均年間がん死亡者数34,799人, 大都市圏：19,419人, 地方：5,515人 / 施設数の推移 Tokyo Metropolitan Government 5施設から19施設 / Major metropolitan areas 26施設から54施設 / Regional policy 27施設から52施設 |
| New initiatives | 医療法人香徳会との連携による医心館 関中央の開設決定, 医心館事業のノウハウを活用した地域医療再生事業への展開構想 |
Items this document does not state (14)
Ordinary incomeGross Profit MarginSegment resultsBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.既存施設の稼働率が87.1％で安定し、新規施設の立ち上がりも堅調だったこと、施設数・定員数の増加、適切なコストコントロールを継続したこと。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.